Pharma

NPIL, Merck in research deal for cancer drugs
NPIL, Merck in research deal for cancer drugs

Nicholas Piramal (NPIL) has reportedly signed a research deal potentially worth a maximum revenue of USD 350 million with US pharmaceutical giant Merck & Co to carry out early discovery and development of two new cancer drugs, the two companies said on Monday.

PCI urges health ministry to amend Pharmacy Act
PCI urges health ministry to amend Pharmacy Act

To enhance the standards of millions of pharmacists in the country, the Pharmacy Council of India (PCI) has urged the Health Ministry to amend the Pharmacy Act to make CEP (continuing education programme) mandatory for registration and subsequent renewal under the Pharmacy Act.

Private Equity investments in pharma touch $400 m
Private Equity investments in pharma touch $400 m

Private Equity (PE) investments in the domestic healthcare and pharma industry have touched around $400 million during the first nine months of the year. This trend is set to accelerate as companies go for overseas acquisitions, hive off their R&D units, and Foreign Currency Convertible Bonds (FCCB) lose their sheen.

whatsapp--v1